Your browser doesn't support javascript.
loading
Reduction in urinary tract infections in patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Tariq, Raseen; Tosh, Pritish K; Pardi, Darrell S; Khanna, Sahil.
Affiliation
  • Tariq R; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Tosh PK; Division of Infectious Diseases, Mayo Clinic, Rochester, MN, USA.
  • Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
  • Khanna S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. khanna.sahil@mayo.edu.
Eur J Clin Microbiol Infect Dis ; 42(8): 1037-1041, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37351724
We performed an updated study to investigate the rates of urinary tract infections (UTIs) in patients with recurrent Clostridioides difficile infection (CDI) who received fecal microbiota transplantation (FMT) for CDI. We found a significant reduction in number of UTIs after FMT compared to patients who received antibiotics for CDI treatment. After FMT, we also observed a trend towards reduction of antibiotic resistance in organisms causing UTI.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Tract Infections / Clostridioides difficile / Clostridium Infections Type of study: Etiology_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Tract Infections / Clostridioides difficile / Clostridium Infections Type of study: Etiology_studies Limits: Humans Language: En Year: 2023 Type: Article